SOPHiA GENETICS SA (SOPH)
NASDAQ: SOPH · Real-Time Price · USD
4.740
+0.060 (1.28%)
May 20, 2026, 3:13 PM EDT - Market open
SOPHiA GENETICS Market Cap
SOPHiA GENETICS has a market cap or net worth of $340.29 million as of May 20, 2026. Its market cap has increased by 62.16% in one year.
Market Cap
340.29M
Enterprise Value
336.47M
1-Year Change
62.16%
Ranking
Category
Stock Price
$4.74
Market Cap Chart
Since the IPO on July 23, 2021, SOPHiA GENETICS's market cap has decreased from $1.12B to $340.29M, a decrease of -69.63%. That is a compound annual growth rate of -21.88%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 19, 2026 | 335.98M | 6.04% |
| Dec 31, 2025 | 316.85M | 55.34% |
| Dec 31, 2024 | 203.97M | -33.51% |
| Dec 29, 2023 | 306.77M | 131.92% |
| Dec 30, 2022 | 132.27M | -85.31% |
| Dec 31, 2021 | 900.39M | -19.63% |
| Jul 23, 2021 | 1.12B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Phreesia | 532.89M |
| Evolent Health | 445.43M |
| Weave Communications | 420.11M |
| NRC Health | 419.63M |
| TruBridge | 382.87M |
| Carlsmed | 299.31M |
| So-Young International | 285.85M |
| Simulations Plus | 269.54M |